Source: Υπουργείο Υγείας (CY) Revision Year: 2014 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medocriptine 2.5 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, round, flat, scored tablet. |
Medocriptine contain 2.5 mg bromocriptine as bromocriptine mesilate.
Excipient with known effect: lactose monohydrate. Each tablet contains 100.0mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Bromocriptine |
Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications. |
| List of Excipients |
|---|
|
Medocriptine contain lactose monohydrate, microcrystalline cellulose, sodium starch glycollate, magnesium stearate, maleic acid and disodium edetate. |
Polyvinylchloride and aluminium combination blisters. Blisters and leaflet in an outer carton.
Medocriptine 2.5 mg tablets are available in packs of 30, 100 or 500 tablets.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
10640
4/7/1986
| Drug | Countries | |
|---|---|---|
| MEDOCRIPTINE | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
